AnPac Bio Announces Appointment of New Directors and Co-Chief Executive Officer
05 août 2022 16h45 HE
|
AnPac Bio-Medical Science Co., Ltd.
PHILADELPHIA, Aug. 05, 2022 (GLOBE NEWSWIRE) -- AnPac Bio-Medical Science Co., Ltd. (“AnPac Bio,” the “Company” or “we”) (ANPC), a biotechnology company with operations in the United States and...
AnPac Bio Approved Written Resolutions of a Majority of the Members Addressing the Removal of Directors and Officers, Re-designation of Officers, and Change of Members of the Committees
18 juil. 2022 18h39 HE
|
AnPac Bio-Medical Science Co., Ltd.
PHILADELPHIA, July 18, 2022 (GLOBE NEWSWIRE) -- AnPac Bio-Medical Science Co., Ltd. (“AnPac Bio,” the “Company” or “we”) (ANPC), a biotechnology company with operations in the United States and...
AnPac Bio Regains Compliance with Requirements to Remain Listed on Nasdaq Capital Market
10 juin 2022 07h30 HE
|
AnPac Bio-Medical Science Co., Ltd.
PHILADELPHIA, June 10, 2022 (GLOBE NEWSWIRE) -- AnPac Bio-Medical Science Co., Ltd. (“AnPac Bio,” the “Company” or “we”) (ANPC), a biotechnology company with operations in the United States and...
AnPac Bio Reports 49.1% Decrease in Net Loss in First Quarter of Fiscal 2022
31 mai 2022 17h00 HE
|
AnPac Bio-Medical Science Co., Ltd.
PHILADELPHIA, May 31, 2022 (GLOBE NEWSWIRE) -- AnPac Bio-Medical Science Co., Ltd. (“AnPac Bio,” the “Company” or “we”) (NASDAQ: ANPC), a biotechnology company with operations in China and the...
AnPac Bio Reports Fiscal Year 2021 Annual Financial Results
16 mai 2022 17h00 HE
|
AnPac Bio-Medical Science Co., Ltd.
PHILADELPHIA, May 16, 2022 (GLOBE NEWSWIRE) -- AnPac Bio-Medical Science Co., Ltd. (“AnPac Bio,” the “Company” or “we”) (NASDAQ: ANPC), a biotechnology company with operations in China and the...
AnPac Bio Regains Compliance with Market-Value-Of-Publicly Held Shares Requirement upon Transfer to The Nasdaq Capital Market
11 mai 2022 07h30 HE
|
AnPac Bio-Medical Science Co., Ltd.
PHILADELPHIA, May 11, 2022 (GLOBE NEWSWIRE) -- AnPac Bio-Medical Science Co., Ltd. (“AnPac Bio,” the “Company” or “we”) (ANPC), a biotechnology company with operations in the United States and China...
Nasdaq Hearing Panel Grants AnPac Bio’s Request to Transfer Securities from The Nasdaq Global Market to The Nasdaq Capital Market
06 mai 2022 07h30 HE
|
AnPac Bio-Medical Science Co., Ltd.
PHILADELPHIA, May 06, 2022 (GLOBE NEWSWIRE) -- AnPac Bio-Medical Science Co., Ltd. (“AnPac Bio,” the “Company” or “we”) (ANPC), a biotechnology company with operations in the United States and China...
AnPac Bio and New Investor Sign Equity Investment Totaling $15 Million
11 avr. 2022 07h30 HE
|
AnPac Bio-Medical Science Co., Ltd.
PHILADELPHIA, April 11, 2022 (GLOBE NEWSWIRE) -- AnPac Bio-Medical Science Co., Ltd. (“AnPac Bio,” the “Company” or “we”) (ANPC), a biotechnology company with operations in the United States and...
AnPac Bio Appoints Dr. Aidong Chen as New Chief Executive Officer and Chairman of the Board and Miss Sheng Liu as a New Board Member
08 avr. 2022 21h12 HE
|
AnPac Bio-Medical Science Co., Ltd.
PHILADELPHIA, April 08, 2022 (GLOBE NEWSWIRE) -- AnPac Bio-Medical Science Co., Ltd. (“AnPac Bio,” the “Company” or “we”) (ANPC), a biotechnology company with operations in the United States and...
AnPac Bio Filed Request for a Hearing Regarding Continued Listing on NASDAQ, The Hearing was Granted and scheduled for Late April
04 avr. 2022 07h30 HE
|
AnPac Bio-Medical Science Co., Ltd.
PHILADELPHIA, April 04, 2022 (GLOBE NEWSWIRE) -- AnPac Bio-Medical Science Co., Ltd. (“AnPac Bio,” the “Company” or “we”) (ANPC), a biotechnology company with operations in the United States and...